Breakthrough Discovery To Treat Prosthetic Joint Infections Youtube The food and drug administration (fda) has granted breakthrough therapy designation to vt x7 for the treatment of periprosthetic joint infection (pji) of the hip and knee. For the 7 million americans living with artificial knees and hips, one of the most serious health threats is an infection near the implant. new research at u.
Diagnosis And Management Of Prosthetic Joint Infection The Bmj The fda designated a drug device combination for periprosthetic joint infection in hip and knee replacement patients as a breakthrough therapy, which may accelerate its approval, the manufacturer said. The duration of antibiotic therapy in patients with prosthetic joint infection is primarily based on expert recommendations rather than evidence. 3,4 patients usually receive long courses of. Prosthetic joint infection (pji) is a severe complication after arthroplasty. its management combines surgical intervention, whose type depends on the clinical situation, and prolonged high dose antibiotics adapted to the responsible microorganism (s) and the patient. antibiotics are only one part of the therapeutic regimen and are closely. A device that uses alternating magnetic fields to treat prosthetic joint infections (pji) on metallic knee implants has received breakthrough device designation from the us food and drug administration (fda), according to solenic medical inc, its developer, in a media release.
Comments are closed.